The Lovenox trial schedule was not determined by mutual agreement between Teva and NVS/MNTA; rather, the schedule was set by the Court itself. This was asked and answered at MNTA’s annual meeting in June (#msg-64248348).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”